ReviewGut and liver2019
Management of Antibiotic-Resistant
Review in Gut and liver, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Efficacy and safety of seven Chinese patent medicines combined with conventional triple/quadruple therapy forBMJ open · 2024Pooled it
- Different dose of new generation proton pump inhibitors for the treatment ofInternational journal of immunopathology and pharmacologyPooled it
- Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial).PloS one · 2023Trial
- The Association betweenGenes · 2020Trial
- Diminishing Efficacy of Second-Line Levofloxacin-Based Quadruple Therapy inAntibiotics (Basel, Switzerland) · 2025Article
- Review
- Antimicrobial susceptibility of clinicalMicrobiology spectrum · 2024Article
- Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates.Scientific reports · 2024Article
- Treatment ofHeliyon · 2023Review
- Current Worldwide Trends in PediatricChildren (Basel, Switzerland) · 2023Review
- Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.Scientific reports · 2022Article
- Scope and Limitations of Current Antibiotic Therapies againstPharmaceutics · 2022Review
- Emergence of amoxicillin resistance and identification of novel mutations of the pbp1A gene in Helicobacter pylori in Vietnam.BMC microbiology · 2022Article
- Effects of Quadruple Therapy Combined with Probiotics onComputational and mathematical methods in medicine · 2022Article
- Vietnam Association of Gastroenterology (VNAGE) consensus on the management ofFrontiers in medicine · 2022Review
- Gastric histopathological features after the administration of omeprazole, amoxicillin, and clarithromycin in gastritisJournal of advanced veterinary and animal research · 2021Article
- Article
- The effect ofVeterinary world · 2020Article
- H. pylori Infection and Colorectal Cancers by Anatomical Locations.Asian Pacific journal of cancer prevention : APJCP · 2020Article
- The effect of snakehead fish extract supplementation to first-line eradication regimen on macrophage migration inhibitory factor (MIF) expression in rats induced byJournal of advanced veterinary and animal research · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.